Latest Industry Insights
Industry Insight
Calculating Gestational Age With Metabolomics
Researchers have developed a mathematical model that may offer an alternative to relying on ultrasound information for calculating gestational age. The model, utilizing a "metabolomic fingerprint" approach, may overcome barriers in preterm death research.
Industry Insight
Flow Chemistry: Successfully Transitioning From Lab to Production
As continuous flow technology takes center stage, we are seeing a transformation in chemical production. To learn more about the transition away from batch-wise approaches to chemical reactions, the advantages and challenges of using flow technology, and how its adoption has impacted the industry we recently spoke with Charlotte Wiles, PhD, CEO at Chemtrix BV.
Industry Insight
No One Size Fits All: The Challenges of Vendor Agnostic Software
Biosero, Inc. develop automation software, that deploys artificial intelligence to speed up critical lab work. We caught up with David Dambman, Biosero’s Director of Engineering, to talk about the challenges of developing agnostic software, and how labs can implement artificial intelligence into their processes.
Industry Insight
Developing Scalable Flow Chemistry for a Variety of Chemical Transformations
We recently spoke to Oliver Kappe to learn more about his research. Kappe highlights the key properties of continuous-flow microreactors that make them well-suited to preparing pharmaceuticals.
Industry Insight
IEX Chromatography Leading the Charge in Charge Variant Analysis
Find out how the biopharmaceutical industry has benefited from advances in chromatography technology, with insights from Matthew Lauber, consulting scientist at Waters.
Industry Insight
Tailoring Flow Reactor Equipment to the Particular Chemistry at Hand
We recently spoke to André de Vries from InnoSyn BV to learn more about the considerations to make when scaling up chemical processes. He outlines the advantages of flow chemistry over batch processes and discusses how to design and manufacture flow reactors for any type of chemistry.
Industry Insight
Take a Good Book Around
Our recent social media poll on "book recommendations for scientists" provided an incredible response. We decided to collate this information and give you the perfect excuse to treat yourself to a new read. Enjoy!
Industry Insight
The Vision for Multi-organ Human-on-a-Chip Models
The development of organ-on-a-chip models aims to reduce the (expensive) high drug failure rates that exist in clinical trials. A Florida biotech firm recently reported that their multi-organ “human-on-a-chip” system maintains cellular viability over 28 days in serum-free conditions, using a pumpless system. To learn more about the vision for multi-organ “human-on-a-chip” models, we caught up with James Hickman, Chief Science Officer of Hesperos Inc.
Industry Insight
Is Off-the-Shelf Immunotherapy the Way Forward?
An “off-the-shelf” immuno-oncology product has been developed whereby T cells are derived from healthy donors, bypassing limitations related to high pricing and limited market access.
Industry Insight
The Booming Business of Neurotoxin Therapy
Botulinum neurotoxins are widely used in both therapeutic and cosmetic applications, but Ipsen says that their new rBoNT-E toxin is a step up from compounds based on the much more widely used serotype A toxin. We spoke to Ipsen Senior Vice President Neurosciences R&D, Philippe Picaut, to find out more.
Advertisement